 |
인쇄하기
취소
|
KFDA to maker public screening review of clinical trial protocol
The Korea Food and Drug Administration unveiled its plan to disclose its screening review concerning protocol, safety and efficacy of drugs, etc. and specification & analytical methods in its web site from next year.
The KFDA said that this will provide transparency into its screening of drug related application documents.
Under the plan, the contents of protocol to be disclosed include a...
The KFDA said that this will provide transparency into its screening of drug related application documents.
Under the plan, the contents of protocol to be disclosed include a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.